First Time Loading...

Prometheus Biosciences Inc
NASDAQ:RXDX

Watchlist Manager
Prometheus Biosciences Inc Logo
Prometheus Biosciences Inc
NASDAQ:RXDX
Watchlist
Price: 199.92 USD 0.09% Market Closed
Updated: Apr 30, 2024
Section:
 

Wall Street
Price Targets

RXDX Price Targets Summary
Prometheus Biosciences Inc

There are no price targets for RXDX.
RXDX Lowest Forecast
Wall Street Target
Not Available
RXDX Average Forecast
Wall Street Target
Not Available
RXDX Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available

RXDX Last Price Targets
Prometheus Biosciences Inc

The latest public price target was made on Apr 16, 2023 by Annabel Samimy from Stifel Nicolaus , who expects RXDX stock to rise by 0% over the next 12 months. You can read more about this price target by viewing the article on TheFly.

Analyst Price Target Date Article
Annabel Samimy
Stifel Nicolaus
200 USD
Upside 0%
1 year ago
Apr 16, 2023
Prometheus downgraded to Hold from Buy at Stifel
TheFly
Unknown Analyst
Goldman Sachs
144 USD
Downside 28%
1 year ago
Jan 31, 2023
Goldman Sachs Maintains Buy on Prometheus Biosciences, Raises Price Target to $144
Benzinga
Annabel Samimy
Stifel Nicolaus
Price Target 200 USD
Upside/Downside 0%
View Source
Unknown Analyst
Goldman Sachs
Price Target 144 USD
Upside/Downside 28%
View Source
Prometheus Biosciences Inc Competitors:
Price Targets
068270
Celltrion Inc
26% Upside
MYGN
Myriad Genetics Inc
26% Upside
GMAB
Genmab A/S
41% Upside
301047
Sino Biological Inc
48% Upside
068270
Celltrion Inc
26% Upside
MYGN
Myriad Genetics Inc
26% Upside
GMAB
Genmab A/S
41% Upside
301047
Sino Biological Inc
48% Upside
MOR
MorphoSys AG
13% Downside
ALNY
Alnylam Pharmaceuticals Inc
54% Upside
B
BLRX
BioLine RX Ltd
82% Downside
N
688105
Nanjing Vazyme Biotech Co Ltd
58% Upside

Revenue
Forecast

Revenue Estimate
Prometheus Biosciences Inc

For the last 3 years the compound annual growth rate for Prometheus Biosciences Inc's revenue is 83%. The projected CAGR for the next 3 years is 137%.

83%
Past Growth
137%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Prometheus Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Prometheus Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
RXDX intrinsic value, competitors valuation, and company profile.
DCF Valuation
RXDX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
RXDX stock valuation using valuation multiples.
Wall Street Estimates
RXDX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
RXDX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is RXDX's stock price target?
Not Available

RXDX doesn't have any price targets made by Wall Street professionals.

What is Prometheus Biosciences Inc's Revenue forecast?
Projected CAGR
137%

For the last 3 years the compound annual growth rate for Prometheus Biosciences Inc's revenue is 83%. The projected CAGR for the next 3 years is 137%.

ALPHA SPREAD
Join more than 132,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.